Document Detail

A safety analysis of oral prednisone as a pretreatment for rituximab in rheumatoid arthritis.
MedLine Citation:
PMID:  22923178     Owner:  NLM     Status:  Publisher    
The administration of 100 mg of methylprednisolone intravenously (IV) 1/2 h prior to rituximab decreases the incidence of acute infusion reactions (AIRs). However, this pretreatment adds considerable time and conveys potential risk. We performed an open-label prospective assessment of oral prednisone as a pretreatment to rituximab. This was a 26-week open-label trial of 40 mg of oral prednisone given 1/2 h prior to rituximab as a prophylaxis against AIRs in patients with rheumatoid arthritis (RA). The primary endpoint was AIRs in the first 24 h after their initial infusion. Secondary endpoints include AIRs during the 24 h following their second infusion and any adverse events experienced during the 26-week study; efficacy measures were also followed as secondary endpoints. Sixty-four subjects were screened, and 50 subjects qualified. Fourteen out of the 50 (28 %) subjects had AIRs within 24 h of their first infusion. There were four AIRs (8.3 %) within 24 h of their second infusion. One of day 0 AIRs required drug discontinuation (wheezing/bronchospasm). Forty out of 50 (80 %) subjects experienced an adverse event during the 26 weeks. There were three SAEs deemed not to be study-drug related. The DAS28 and HAQ-DI all improved significantly at weeks 8, 16, and 26 compared to baseline. Historical controls demonstrate that 27 % of RA subjects experience AIRs with their first rituximab infusion. Our data suggest a smaller dose of oral prednisone is an effective alternative to IV methylprednisolone as a pretreatment for rituximab in patients with RA.
J D Carter; S A Zarabadi; L R Ricca; A McNeil; J Valeriano-Marcet; F B Vasey; A I Sebba
Related Documents :
22529478 - Zimelidine attenuates the development of tolerance to morphine-induced antinociception.
22865488 - The antinociceptive effects of systemic administration of tramadol, gabapentin and thei...
25351168 - Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies.
23167508 - Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in...
315388 - Mutation and inactivation of cultured mammalian cells exposed to beams of accelerated h...
24372968 - Coagulation, oncotic and haemodilutional effects of a third generation hydroxyethyl sta...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-26
Journal Detail:
Title:  Clinical rheumatology     Volume:  -     ISSN:  1434-9949     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Internal Medicine, Division of Rheumatology, University of South Florida, Tampa, FL, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matr...
Next Document:  Shrinking lung syndrome masked by pleuropericarditis: a case report and review of the literature.